Empowering Discovery,
Enhancing Knowledge
Latest News
UAB O’Neal Cancer Center research advances precision imaging through multi-color MRI technology
New MRI approach detects tiny lung tumors and metastases in preclinical study
New MRI Agent Detects Lung Cancer, Hidden Metastases Earlier Than Current Scans
InLighta BioSciences Awarded NIH Grant
InLighta BioSciences, a start-up company led by Jenny Yang, Regents’ Professor of Chemistry at Georgia State University, has been awarded an NIH grant to accelerate development of a magnetic resonance imaging contrast agent to detect liver fibrosis.
InLighta Patents
InLighta® BioSciences L.L.C. currently has exclusive operational agreement with Georgia State University for a robust patent portfolio related to targeted and non-targeted protein-based contrast agents in the U.S. and international markets.
Key Patents Issued Include:
Contrast Agents and Methods for Preparing Contrast Agents: CA2614486, CN101222878, EP1901659, US8173105, US8367040.
Targeted Contrast Agents and Methods for Targeting Contrast Agents: CA2621763, EP1928507, US9339559, US10525150.
Contrast Agents Methods for Preparing Contrast Agents, and Methods of Imaging: EP2257316, US9956304, US10849993.
Targeted Protein Contrast Agents, Methods of Making and Uses Thereof: US10814020, US11419954, US11426471, US12491268.
Academic Papers and Presentations by Dr. Jenny Yang
Explore Dr. Jenny Yang’s related academic papers, conference presentations, and more.